Leptin serum levels as a marker of MRI disease activity during IFN beta therapy in multiple sclerosis

被引：0
|
作者：
Tomassini, V
Angelucci, F
Batocchi, AP
Mirabella, M
Onesti, E
Paolillo, A
Russo, P
Pozzilli, C
Tonali, PA
机构：
来源：
NEUROLOGY | 2005年 / 64卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A328 / A328
页数：1
相关论文
共 50 条
  • [31] SERUM LEVELS OF BETA-2-MICROGLOBULIN - NEW MARKER OF ACTIVITY IN CROHNS-DISEASE
    DESCOS, L
    ANDRE, C
    BEORCHIA, S
    VINCENT, C
    REVILLARD, JP
    NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (08): : 440 - 441
  • [32] Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy
    Angelucci, F
    Mirabella, M
    Frisullo, G
    Caggiula, M
    Tonali, PA
    Batocchi, AP
    DISEASE MARKERS, 2005, 21 (02) : 49 - 55
  • [33] Early MRI activity during interferon beta-1a therapy predicts disease activity at 5 years in patients at high risk for developing clinically definite multiple sclerosis
    Kinkel, R. P.
    Pace, A.
    Simon, J.
    O'Connor, P. W.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S129 - S129
  • [34] Significance of serum neutralising antibodies to Avonex' (IFN beta-1a) in multiple sclerosis
    Rudick, RA
    Jones, W
    Alam, J
    Simonian, N
    Campion, M
    Jacobs, L
    Herndon, R
    Richert, J
    Salazar, A
    Cookfair, D
    Simon, J
    Coats, M
    Goodkin, D
    Mass, M
    NEUROLOGY, 1997, 48 (03) : 5003 - 5003
  • [35] Is periphlebitis retinae a marker of disease activity in the course of multiple sclerosis?
    Rosche, J
    Mauch, E
    Kornhuber, HH
    NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH, 1996, 4 (03) : 109 - 112
  • [36] Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis
    Nature Clinical Practice Neurology, 2006, 2 (9): : 464 - 464
  • [37] IFN-beta impairs plasmacytoid dendritic cell maturation: A novel target for IFN-beta therapy in multiple sclerosis
    Lande, Roberto
    Gafa, Valerie
    Serafini, Barbara
    Giacomini, Elena
    Salvetti, Marco
    Remoli, Maria E.
    Severa, Martina
    Parmentier, Marc
    Aloisi, Francesca
    Coccia, Eliana M.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2007, 27 (08): : 705 - 705
  • [38] Serum endocan levels as a marker of disease activity in patients with Behcet disease
    Balta, Ilknur
    Balta, Sevket
    Koryurek, Ozgul Mustu
    Demirkol, Sait
    Mikhailidis, Dimitri P.
    Celik, Turgay
    Cakar, Mustafa
    Kucuk, Ugur
    Eksioglu, Meral
    Kurt, Yasemin Gulcan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (02) : 291 - 296
  • [39] Serum levels of soluble CD14 correlate with disease activity in multiple sclerosis patients and are increased by interferon-beta treatment
    Lutterotti, A.
    Kuenz, B.
    Khalil, M.
    Gredler, V.
    Ehling, R.
    Gneiss, C.
    Deisenhammer, F.
    Berger, T.
    Reindl, M.
    MULTIPLE SCLEROSIS, 2006, 12 : S66 - S66
  • [40] Temporal relationship of serum neurofilament light levels and radiological disease activity in patients with multiple sclerosis
    Fox, R.
    Cree, B. A. C.
    De Seze, J.
    Gold, R.
    Hartung, H. -P.
    Jeffery, D.
    Kappos, L.
    Montalban, X.
    Weinstock-Guttman, B.
    Singh, C. M.
    Campbell, N.
    Ho, P. -R.
    Su, R.
    Engle, B.
    Sangurdekar, D.
    de Moor, C.
    Fisher, E.
    Kieseier, B. C.
    Rudick, R. A.
    Plavina, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 244 - 246
12345